Audience
Health professionals and providers searching for a solution to deliver better patient outcomes
About BrainFx
Specifically designed to detect what other cognitive tests can miss, BrainFx’s interactive digital cognitive assessments help health professionals better understand a person’s neurofunction, quickly illuminate mild to moderate dysfunction and deliver unique insights for creating more, targeted treatment plans through real-world contextual, function-based activities. BrainFx assessments use the innovative Neurofunctional approach to assessing cognitive function. This means that you assess more than just cognition because, in the real-world, other factors like one’s psychosocial and physical health, or environmental and task-related characteristics can positively or negatively influence cognitive function. By taking the Neurofunctional approach in the design of the assessments, BrainFx’s activities can be more real-world and function-based, more challenging, and ultimately more sensitive. This enables BrainFx assessments to detect what other tests can often miss.
Other Popular Alternatives & Related Software
Cognistat Assessment System
Cognistat is the leading cognitive test for assessing the five major cognitive ability areas: language, spatial skills, memory, calculations and reasoning. Cognistat was developed at Stanford University and is standardized for adolescents, adults and seniors (60 – 84). It can be administered by any suitably trained healthcare professional. The Cognistat assessment and screening test has been culturally adapted with clinical validity in many languages by collaborating with important universities, academic institutions and customers worldwide. With over 400 peer-reviewed scientific articles, Cognistat’s use in patients with stroke, dementia, traumatic brain injury, major psychiatric disorders and substance abuse is well documented. The Cognistat Assessment System preserves the strengths of the highly regarded paper and pencil version of Cognistat: Assesses five major areas of cognitive functioning, gives a quick yet comprehensive evaluation, utilizes a screen and metric approach.
Learn more
HBDI
The Herrmann Brain Dominance Instrument (HBDI) is a 116-question, highly validated diagnostic survey that measures thinking preferences across four integrated systems, metaphorically mapped onto the brain's quadrants. Developed by Ned Herrmann during his tenure as management education leader at General Electric, the HBDI was created to assess how thought processes and thinking preferences impact management and leadership development. Unlike other assessments that focus on behavior or personality, the HBDI provides insight into an individual's thinking preferences, influencing their approach to problem-solving and decision-making. It does not measure ability, aptitude, or capabilities, nor does it assess activity in specific localized areas of the brain. The HBDI has been utilized by over 4 million people in more than 60 countries and is available in 16 languages. It serves as a foundational tool for organizations aiming to harness cognitive diversity.
Learn more
CANTAB
Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test Automated Battery (CANTAB) includes highly sensitive, precise and objective measures of cognitive function, correlated to neural networks. CANTAB tests have demonstrated sensitivity to detecting changes in neuropsychological performance and include tests of working memory, learning and executive function; visual, verbal and episodic memory; attention, information processing and reaction time; social and emotion recognition, decision making and response control. Cognitive assessments are invaluable tools for understanding the role of specific brain functions across a range of disorders and syndromes; giving insight into underlying causes, identifying ways to detect the earliest symptoms and evaluating the effects of interventions designed to improve brain health.
Learn more
MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
Pricing
Starting Price:
$49 per month
Free Trial:
Free Trial available.
Integrations
Company Information
BrainFx
Canada
www.brainfx.com
Videos and Screen Captures
Other Useful Business Software
Streamline Azure Security with Palo Alto Networks VM-Series
Improve your security posture and reduce incident response time. Use the VM-Series to natively analyze Azure traffic and dynamically drive policy updates based on workload changes.
Product Details
Platforms Supported
Cloud
Training
Documentation
Live Online
Webinars
In Person
Support
Phone Support
24/7 Live Support
Online
